elacridar has been researched along with gw420867x in 1 studies
Studies (elacridar) | Trials (elacridar) | Recent Studies (post-2010) (elacridar) | Studies (gw420867x) | Trials (gw420867x) | Recent Studies (post-2010) (gw420867x) |
---|---|---|---|---|---|
284 | 8 | 119 | 17 | 5 | 2 |
Protein | Taxonomy | elacridar (IC50) | gw420867x (IC50) |
---|---|---|---|
Gag-Pol polyprotein | HIV-1 M:B_HXB2R | 0.179 | |
Reverse transcriptase/RNaseH | Human immunodeficiency virus 1 | 0.112 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Huang, L; Humphreys, JE; Morgan, JB; Polli, JW; Serabjit-Singh, CS; Webster, LO; Wring, SA | 1 |
1 other study(ies) available for elacridar and gw420867x
Article | Year |
---|---|
Rational use of in vitro P-glycoprotein assays in drug discovery.
Topics: Adenosine Triphosphatases; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cells, Cultured; Chromatography, Liquid; Enzyme Inhibitors; Fluoresceins; Fluorescent Dyes; Humans; Mass Spectrometry; Pharmacology; Spodoptera | 2001 |